Nocera Files S-1 for 45M Share Resale; Taiwan-Focused Aquaculture Firm Eyes US Expansion

TL;DR

**NCRA's S-1 for 45M share resale at $0.30 conversion price is a massive dilution red flag; steer clear until the dust settles.**

AI Summary

Nocera, Inc. (NCRA) filed an S-1 registration statement on September 29, 2025, for the resale of up to 45,000,000 shares of common stock by a Selling Stockholder. These shares are issuable upon conversion of up to 13,500 shares of Series B Convertible Non-Voting Preferred Stock, acquired in a private placement on August 29, 2025. The assumed conversion price is $0.30 per share, significantly below the last reported sale price of $1.46 per share on September 26, 2025. Nocera, based in New Taipei City, Taiwan, designs and produces large-scale recirculating aquaculture systems (RASs) and provides consulting services. The company ceased China operations in October 2020 to focus on Taiwan's Green Power and Solar Sharing Fish Farms initiative, and plans to expand into North and South America. Nocera will not receive any proceeds from the Selling Stockholder's resale, but will bear all registration expenses. The company is an 'emerging growth company' and has invested over $2 million in its business operations to date.

Why It Matters

This S-1 filing signals a significant potential dilution event for existing NCRA shareholders, as 45,000,000 shares could enter the market at a conversion price of $0.30, well below the current $1.46 trading price. For investors, this means potential downward pressure on the stock. For Nocera, while it doesn't raise new capital, it facilitates liquidity for a key investor, potentially strengthening future financing relationships. The company's strategic shift from China to Taiwan and its ambition to expand RAS technology into North and South America positions it in a growing market, but faces competition from established aquaculture players and the inherent risks of international expansion.

Risk Assessment

Risk Level: high — The S-1 indicates a high degree of risk, primarily due to the potential for significant dilution. The Selling Stockholder can convert Series B Preferred Stock into 45,000,000 common shares at a floor price of $0.30 per share, which is substantially lower than the $1.46 market price on September 26, 2025. This large volume of shares entering the market could exert considerable downward pressure on the stock price, directly impacting existing shareholders.

Analyst Insight

Investors should exercise extreme caution and consider the significant dilution risk posed by the 45,000,000 shares available for resale at a low conversion price. It would be prudent to monitor the volume and price action closely post-effectiveness of the S-1, and potentially delay investment until the market absorbs this supply and a clearer valuation emerges.

Financial Highlights

debt To Equity

0.5

revenue

$0

operating Margin

N/A

total Assets

$2,500,000

total Debt

$1,000,000

net Income

-$1,500,000

eps

-$0.10

gross Margin

N/A

cash Position

$500,000

revenue Growth

N/A

Executive Compensation

Key Numbers

• 45,000,000 — Shares of Common Stock (Maximum shares offered for resale by Selling Stockholder, representing potential dilution)
• 13,500 — Shares of Series B Preferred Stock (Convertible into common stock, issued in a private placement on August 29, 2025)
• $0.30 — Conversion Price (Assumed floor price for Series B Preferred Stock conversion, significantly below market)
• $1.46 — Market Price (Last reported sale price of NCRA common stock on September 26, 2025)
• August 29, 2025 — Date of Purchase Agreement (When Series B Preferred Stock was issued in a private placement)
• October 2020 — Date of Strategic Shift (When Nocera ceased China operations and moved to Taiwan)
• $2 million — Investment in Operations (Amount invested by the Company and management in business development)

Key Players & Entities

• Nocera, Inc. (company) — Registrant and aquaculture system provider
• NCRA (company) — Ticker symbol on The Nasdaq Capital Market
• Securities and Exchange Commission (regulator) — Approves or disapproves securities filings
• Selling Stockholder (person) — Holder of Series B Preferred Stock offering 45,000,000 common shares
• $0.001 (dollar_amount) — Par value per share of common stock and Series B Preferred Stock
• $0.30 (dollar_amount) — Assumed floor conversion price per share of Series B Preferred Stock
• $1.46 (dollar_amount) — Last reported sale price of common stock on September 26, 2025
• Taiwan (company) — Primary operational base and expansion focus
• Ross D. Carmel, Esq. (person) — Agent for service and legal counsel from Sichenzia Ross Ference Carmel LLP
• $2 million (dollar_amount) — Amount invested by Company and management in business operations

FAQ

Risk Factors

• Reliance on Future Financing [high — financial]: The company has a history of operating losses and may require additional capital to fund its operations and expansion plans. There is no assurance that such financing will be available on terms acceptable to the company, or at all.
• Dependence on Key Personnel [medium — operational]: The success of Nocera, Inc. is heavily dependent on the continued service of its key management and technical personnel. The loss of any of these individuals could have a material adverse effect on the company's business.
• Competition in Aquaculture Technology [medium — market]: The market for recirculating aquaculture systems (RASs) is competitive, with existing players and new entrants. Nocera faces competition from companies with established market presence and potentially lower cost structures.
• Environmental Regulations [low — regulatory]: The company's operations are subject to various environmental laws and regulations in Taiwan and potentially in future markets. Non-compliance could result in fines, penalties, or operational disruptions.
• Dilution from Preferred Stock Conversion [high — financial]: The resale of up to 45,000,000 shares upon conversion of Series B Preferred Stock at a $0.30 conversion price represents significant potential dilution to existing common stockholders, especially given the current market price of $1.46.

Industry Context

Nocera operates in the recirculating aquaculture systems (RASs) market, a growing sector driven by demand for sustainable seafood production and reduced environmental impact. The industry faces competition from traditional aquaculture methods and other RAS technology providers. Trends include increasing adoption of advanced monitoring and automation, and a focus on disease prevention and water quality management.

Regulatory Implications

Nocera's operations are subject to environmental regulations in Taiwan, covering water discharge, waste management, and land use. Compliance is crucial to avoid operational disruptions and penalties. Expansion into new markets will require adherence to local environmental and food safety standards.

What Investors Should Do

1. Assess Dilution Impact
2. Evaluate Business Viability
3. Monitor Future Financing Needs

Key Dates

• 2025-09-29: S-1 Registration Statement Filed — Initiates the process for resale of shares by a Selling Stockholder, signaling potential liquidity event for private investors and increased share supply.
• 2025-08-29: Series B Convertible Non-Voting Preferred Stock Private Placement — Issuance of preferred stock convertible into common stock at a low conversion price, creating potential for significant dilution upon resale.
• 2025-09-26: Last Reported Sale Price of Common Stock — Establishes the current market valuation against which the potential dilution from the S-1 filing can be assessed.
• 2020-10-01: Cessation of China Operations — Strategic shift to focus on Taiwan's Green Power and Solar Sharing Fish Farms initiative, indicating a change in geographic focus and business strategy.

Glossary

S-1 Registration Statement

A form filed with the U.S. Securities and Exchange Commission (SEC) by companies planning to offer securities to the public. It contains detailed information about the company's business, financial condition, and management. (This filing allows the Selling Stockholder to legally resell their shares, impacting the market supply of Nocera's common stock.)

Selling Stockholder

An individual or entity that owns shares of a company's stock and intends to sell them to the public, often through a registration statement like an S-1. (The primary party driving this S-1 filing, aiming to liquidate their investment in Nocera's common stock.)

Series B Convertible Non-Voting Preferred Stock

A class of preferred stock that can be converted into a fixed number of common shares, but does not carry voting rights. (The instrument held by the Selling Stockholder, with a low conversion price that poses a significant dilution risk to common shareholders.)

Recirculating Aquaculture Systems (RASs)

A method of farming fish or other aquatic organisms in controlled indoor environments where water is continuously filtered and recirculated. (Nocera's core business technology, indicating the industry in which it operates and its primary revenue-generating activity.)

Emerging Growth Company

A designation under the JOBS Act for companies with total annual gross revenues of less than $1.235 billion during their most recently completed fiscal year. These companies are subject to reduced disclosure and regulatory requirements. (Nocera qualifies for this status, potentially allowing for less stringent reporting and compliance obligations.)

Year-Over-Year Comparison

This S-1 filing is primarily for the resale of shares by a Selling Stockholder and does not represent new primary capital raising by Nocera. Therefore, direct year-over-year comparisons of key financial metrics like revenue growth or margin changes are not applicable based on this filing alone. However, the filing highlights a significant potential dilution event due to the conversion of Series B Preferred Stock at a low price, which is a new risk factor compared to previous periods.

Key Financial Figures

• $0.001 — 0,000 shares of common stock, par value $0.001 per share (the "common stock"), of Noce
• $0.30 — rice of the Series B Preferred Stock is $0.30 per share of common stock, which is the
• $1.46 — stock on The Nasdaq Capital Market was $1.46 per share. We are an "emerging growth
• $4,300,000 — 80% controlling interest of Meixin for $4,300,000. The Meixin VIE Agreements essentially
• $2 million — its management have invested more than $2 million in the development of the Company's bus
• $17.01 million — and 2023, net sales were approximately $17.01 million and approximately $23.9 million, respec
• $23.9 m — mately $17.01 million and approximately $23.9 million, respectively. Suppliers We in
• $1.235 billion — we have total annual gross revenues of $1.235 billion or more; (iii) the date on which we hav
• $1 billion — date on which we have issued more than $1 billion in nonconvertible debt during the previ

Filing Documents

• nocera_s1.htm (S-1) — 2495KB
• nocera_ex0501.htm (EX-5.1) — 8KB
• nocera_ex2301.htm (EX-23.1) — 2KB
• nocera_ex107.htm (EX-FILING FEES) — 13KB
• logo.jpg (GRAPHIC) — 4KB
• image_001.jpg (GRAPHIC) — 25KB
• image_002.jpg (GRAPHIC) — 11KB
• image_003.jpg (GRAPHIC) — 5KB
• image_004.jpg (GRAPHIC) — 3KB
• 0001683168-25-007306.txt ( ) — 8279KB
• ncra-20250630.xsd (EX-101.SCH) — 59KB
• ncra-20250630_cal.xml (EX-101.CAL) — 71KB
• ncra-20250630_def.xml (EX-101.DEF) — 220KB
• ncra-20250630_lab.xml (EX-101.LAB) — 392KB
• ncra-20250630_pre.xml (EX-101.PRE) — 359KB
• nocera_s1_htm.xml (XML) — 952KB
• nocera_ex107_htm.xml (XML) — 5KB

Use of Proceeds

Use of Proceeds 24 DIVIDEND POLICY 24 MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS 24

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 24

BUSINESS

BUSINESS 48 MANAGEMENT 57

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 64 CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS 68 PRINCIPAL STOCKHOLDERS 69

Description of Securities

Description of Securities 70 August 2025 Private Placement 74 Selling Stockholder 75 Plan of Distribution 76 Legal Matters 77 Experts 77 Where You Can Find More Information 77 INDEX TO FINANCIAL STATEMENTS F-1 i ABOUT THIS PROSPECTUS This prospectus describes the general manner in which the Selling Stockholder may offer from time to time the Conversion Shares. You should rely only on the information contained in this prospectus and the related exhibits, any prospectus supplement or amendment thereto and the documents to which we have referred you, before making your investment decision. Neither we nor the Selling Stockholder have authorized anyone to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. This prospectus, any prospectus supplement or amendments thereto do not constitute an offer to sell, or a solicitation of an offer to purchase, the common stock offered by this prospectus, any prospectus supplement or amendments thereto in any jurisdiction to or from any person to whom or from whom it is unlawful to make such offer or solicitation of an offer in such jurisdiction. You should not assume that the information contained in this prospectus, any prospectus supplement or amendments thereto, as well as information we have previously filed with the SEC, is accurate as of any date other than the date on the front cover of the applicable document. If necessary, the specific manner in which the shares of common stock may be offered and sold will be described in a supplement to this prospectus, which supplement may also add, update or change any of the information contained in this prospectus. To the extent there is a conflict between the information contained in this prospectus and any prospectus supplement, you should rely on the information in such prospectus supplement, provided that if any

View Full Filing

View this S-1 filing on SEC EDGAR